MARKET

ACON

ACON

Aclarion Inc
NASDAQ
2.340
+0.030
+1.30%
Opening 13:34 10/09 EDT
OPEN
2.345
PREV CLOSE
2.310
HIGH
2.365
LOW
2.330
VOLUME
5.58K
TURNOVER
--
52 WEEK HIGH
12.03
52 WEEK LOW
1.950
MARKET CAP
6.74M
P/E (TTM)
-0.2953
1D
5D
1M
3M
1Y
5Y
1D
Aclarion broadens CLARITY trial enrollment criteria
TipRanks · 1d ago
Weekly Report: what happened at ACON last week (0928-1002)?
Weekly Report · 4d ago
Aclarion announces NYU Langone Health as new clinical site for CLARITY trial
TipRanks · 09/29 11:15
Weekly Report: what happened at ACON last week (0921-0925)?
Weekly Report · 09/28 09:52
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga · 09/24 12:05
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga · 09/23 21:05
Aclarion Has Received A Decision To Grant European Patent Number EP3056919 Titled "MR SPECTROSCOPY SYSTEM AND METHOD FOR DIAGNOSING PAINFUL AND NON-PAINFUL INTERVERTEBRAL DISCS"
Benzinga · 09/23 20:00
Weekly Report: what happened at ACON last week (0914-0918)?
Weekly Report · 09/21 09:52
More
About ACON
Aclarion, Inc. is a healthcare technology company. The Company leverages magnetic resonance spectroscopy (MRS) and proprietary biomarkers to optimize clinical treatments. The Company has developed a software application called NOCISCAN. The product uses the existing MRS capabilities of many commercially available scanners to non-invasively analyze the chemical makeup of intervertebral discs in the spine. The software post-processes the MRS exam data and detects the presence of chemical biomarkers that Aclarion, in conjunction with spine researchers at University of California San Francisco (UCSF), have demonstrated to be associated with degenerative pain and structural integrity of the lumbar discs. After processing the MRS exam data, the Company sends the ordering clinician a report that details how to interpret the results of the MRS exam. The platform used to conduct a NOCISCAN involves a diagnostic report called a Nocigram that identifies discs as painful or not.

Webull offers Aclarion Inc stock information, including NASDAQ: ACON real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ACON stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ACON stock methods without spending real money on the virtual paper trading platform.